Literature DB >> 6891818

Diazepam in high doses is effective in schizophrenia.

J N Nestoros, B E Suranyi-Cadotte, R C Spees, G Schwartz, N P Nair.   

Abstract

1. Diazepam in high doses, up to 400 mg per day, was administered to paranoid schizophrenic patients in a double-blind placebo-controlled study. 2. The effects of treatment were assessed by the following: the Brief Psychiatric Rating Scale (BPRS); the Clinical Global Impressions Scale (CGI); the Schizophrenia Subscale of the Present State Examination (SS-PSE); the Simpson-Angus Rating Scale (SARS) for extrapyramidal symptoms; the Nurses' Observation Scale for Inpatient Evaluation (NOSIE); and a 90 item Self-Assessment Questionnaire (SCL-90). 3. Within a few hours to a few days from the onset of diazepam treatment both positive (such as auditory hallucinations and persecutory delusions) and negative (such as emotional withdrawal and blunted affect) schizophrenic symptoms were dramatically eliminated in 5 out of the 6 patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6891818     DOI: 10.1016/s0278-5846(82)80141-3

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  9 in total

1.  Heritability and familiality of psychopathologic dimensions in Korean families with schizophrenia.

Authors:  Hwagyu Suh; Byung Dae Lee; Je Min Park; Young Min Lee; Eunsoo Moon; Hee Jeong Jeong; Soo Yeon Kim; Kang Yoon Lee; Young In Chung
Journal:  Psychiatry Clin Neurosci       Date:  2019-02-02       Impact factor: 5.188

2.  Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine.

Authors: 
Journal:  BMJ       Date:  2003-09-27

3.  High dose diazepam treatment and its effect on prolactin secretion in adolescent schizophrenic patients.

Authors:  A Weizman; S Tyano; H Wijsenbeek; M Ben David
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

4.  Benzodiazepines in psychotic States.

Authors:  J Ananth; O Solano
Journal:  Indian J Psychiatry       Date:  1993-04       Impact factor: 1.759

Review 5.  Benzodiazepines for schizophrenia.

Authors:  Markus Dold; Chunbo Li; Magdolna Tardy; Vesal Khorsand; Donna Gillies; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

Review 6.  Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: two sides of the same coin?

Authors:  M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

7.  CSF levels of diazepam-binding inhibitor correlate with REM latency in schizophrenia, a pilot study.

Authors:  D P van Kammen; A Guidotti; T Neylan; P Guarneri; M E Kelley; J Gurklis; M W Gilbertson; J L Peters; E Costa
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

8.  Current practices in managing acutely disturbed patients at three hospitals in Rio de Janeiro-Brazil: a prevalence study.

Authors:  Gisele Huf; Evandro da Silva Freire Coutinho; Hugo M Fagundes; Edmar S Oliveira; Jose Ramon R A Lopez; Marcio Gewandszajder; Andreia da Luz Carvalho; Alexandre Keusen; Clive E Adams
Journal:  BMC Psychiatry       Date:  2002-01-22       Impact factor: 3.630

9.  Infra-Low Frequency Neurofeedback rapidly ameliorates schizophrenia symptoms: A case report of the first session.

Authors:  Joannis N Nestoros; Nionia G Vallianatou
Journal:  Front Hum Neurosci       Date:  2022-09-21       Impact factor: 3.473

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.